LynxDx
Healthcare Services · Michigan, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
333 Jackson Plz Ste 600, Ann Arbor, Mich...Phone Number
(734) 212-6561Website
www.lynxdx.comRevenue
<$5 MillionIndustry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
3
3
4
4
About LynxDx
Lynx Dx specializes in advanced diagnostic testing services, particularly focusing on prostate cancer risk assessment through their innovative MyProstateScore 2.0 (MPS2) tool. This urine test analyzes 18 unique gene transcripts to predict the presence of clinically significant prostate cancer, offering flexibility for both providers and patients. Their services are designed to enhance patient care and decision-making, providing individualized reports tailored to each patient's clinical context. Lynx Dx aims to support healthcare providers and patients in navigating the complexities of prostate cancer screening and management.Explore more
LynxDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LynxDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
LynxDx, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if LynxDx is spiking on competitors!
Funding: Get notified immidiatlly once LynxDx has new funding data
Earning: See what the market has to say on LynxDx recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if LynxDx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if LynxDx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when LynxDx launches new products
Congratulate Masked Content for being promoted to Masked Content at LynxDx
Recommended Actions
Find VP level buyers at LynxDx
Find more new buyers
Compare Similar Companies to LynxDx
Compare insights from companies similar to LynxDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LynxDx is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
LynxDx is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about LynxDx.
LynxDx Tech Stack
A closer look at the technologies used by LynxDx
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Management Move
LynxDx has announced that Shawn Wheeler has been a;ppointed to the role of Senior Director, Market Access. Previously, Wheeler served as the National Accounts Manager (Commercial Markets) for Exact Sciences.
Open Position
LynxDx News & Media
New Analytical Validation Confirms Accuracy and Precision of MyProstateScore 2.0
Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. ANN ARBOR, Mich., April 7, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, announces the publication of a comprehensive analytical validation study of its flagship test,...Lynx Dx Launches Ordering for At-Home Collection Version of MyProstateScore 2.0
Convenient test now available for ordering by physicians, eligible for Medicare reimbursement. ANN ARBOR, Mich., Feb. 20, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, today announced the commercial launch of MyProstateScore 2.0 (MPS2) for at-home collection...Lynx Dx Introduces At-Home Collection Option for MyProstateScore 2.0
Revolutionizing Prostate Cancer Risk Assessment with a More Patient-Centered Approach ANN ARBOR, Mich., Feb. 03, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, announced today that its pioneering MyProstateScore 2.0 (MPS2) will be made available for at-home...Lynx Dx Announces Medicare Coverage for MyProstateScore 2.0, Marking a Major Milestone in Prostate Cancer Risk Assessment
ANN ARBOR, Mich., Nov. 18, 2024 /PRNewswire/ -- Lynx Dx, a leader in advanced diagnostic solutions for prostate cancer, is proud to announce that MyProstateScore 2.0 (MPS2) has been approved for coverage from Medicare, effective Sept. 11, 2024, following a successful technical assessment...
Read more news
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LynxDx
Sign Up For FreeTo access detailed company insights
Lynx Dx specializes in advanced diagnostic testing services, particularly focusing on prostate cancer risk assessment through their innovative MyProstateScore 2.0 (MPS2) tool. This urine test analyzes 18 unique gene transcripts to predict the presence of clinically significant prostate cancer, offering flexibility for both providers and patients. T... Read More
